The Alzheimer's disease mitochondrial cascade hypothesis: an update.
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical mechanism-based framework without systematic review methodology or original human data
PubMed 19416677 · doi:10.1016/j.expneurol.2009.01.011
What was done
Narrative review updating the 2004 mitochondrial cascade hypothesis for sporadic Alzheimer's disease (AD). The authors reviewed the reasoning behind the hypothesis, integrated aging theory and evidence that AD pathology is systemic, and synthesized interim data.
What was found
The abstract reports no empirical numbers or quantitative findings. It outlines the conceptual framework: inheritance dictates mitochondrial baseline function and durability, durability dictates age-related mitochondrial change rates, and reaching a threshold of mitochondrial dysfunction triggers AD histopathology and clinical symptoms.
Why it matters
It offers a mechanistic alternative to the amyloid cascade hypothesis by positioning mitochondrial bioenergetics and aging as upstream drivers of sporadic Alzheimer's disease pathogenesis.
Limits
This is a narrative review and theoretical framework containing no original human empirical data, clinical trial outcomes, or quantitative metrics. Systematic search criteria and study counts are not reported in the abstract.
Cited by
- context The majority of dementia cases stem from mitochondrial dysfunction rather than rare inherited genetic mutations.